No detectable untoward consequences on nonneoplastic cells, in vitro. Although it blocks competitively the binding of dihydrotestosterone (DHT) to its protein receptor, it's got no significant consequences on either estrogen or progesterone receptors. Cioteronel [CPC 10997, Cyoctol®, X-Andron] is definitely an antiandrogen agent which was in phase II trials for https://celgosivir13579.creacionblog.com/26578987/top-guidelines-of-dabrafenib